NXP/Qualcomm EC Approval Most Likely Early-to-Mid January

Competition partners following the NXP/Qualcomm case at the European Commission say that any final decision on Qualcomm and NXP is unlikely this year, thoughfeatured

Bayer Waiting on Mid-December State-of-Play Meeting

Bayer is not likely to offer formal concessions to the European Commission for its deal with Monsanto ahead of an anticipated state-of-play meetingfeatured

NXP/Qualcomm Deal Completion Not Expected Until 2018, Sources Say

A recent report claimed that Qualcomm will win European Commission approval for its acquisition of NXP Semiconductors by the end of the year, after striking a final deal with regulators on patent licensing issues. To Keep Reading, Request a Trial Already a subscriber? Log-infeatured

Sources: If Bayer Acquisition of Monsanto Includes a Statement of Objections, it Will Likely Happen in January

With additional reporting by Valeria Camerino. According to a source close to Monsanto, the team at the European Commission looking at the Monsanto/Bayer deal is overloaded with data which it still needs to review.featured

Source Sees a 4 to 5 Year Extension for Glyphosate in the EU

A source close to Monsanto told CTFN he expects EU approval of glyphosate is likely to be granted To Keep Reading, Request a Trial Already a subscriber? Log-infeatured

360b / Shutterstock.com

Qualcomm Antitrust Cases Slowing Review of NXP Merger

The two pending formal antitrust investigations launched by the European Commission into Qualcomm’s possible abusive business practices are causing delays in the EC’sfeatured

Third Parties Say Remedies in NXP/Qualcomm Merger Need Improvement

Sources advising third parties in the European Commission’s review of the acquisition of NXP Semiconductors by Qualcomm told CTFN thatfeatured

Bayer Agreement with BASF Does Not Answer All EC Antitrust Issues

Last week BASF agreed to acquire significant parts of Bayer’s seed and non-selective herbicide businesses for $7 billion, but the deal does not answer all offeatured

Monsanto/Bayer Early Remedy Package Not Expected at European Commission

As the European Commission’s review of Bayer’s acquisition of Monsanto proceeds, Bayer is not planning to proactively offer remedies to the commission beyond thosefeatured

Monsanto/Bayer Expected to Receive Statement of Objections from European Commission

Bayer is expected to receive a statement of objections from the European Commission as the regulator works through its phase II review of Bayer’s acquisition of Monsanto, severalfeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.